ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

LIPO Lipella Pharmaceuticals Inc

0.75
0.00 (0.00%)
プレマーケット
最終更新日: 17:00:00
15分遅延
名称 銘柄コード 市場 種別
Lipella Pharmaceuticals Inc LIPO NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 0.75 17:00:00
始値 安値 高値 終値 前日終値
0.75
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1721:00GLOBELipella Pharmaceuticals Expands its Advisory Board to..
2024/4/0521:00GLOBELipella Pharmaceuticals to Publish Abstract Detailing..
2024/4/0321:00GLOBELipella Pharmaceuticals Announces FDA Type C Meeting for..
2024/3/0805:23GLOBEPRISM MarketView Spotlights Lipella Pharmaceuticals as it..
2024/3/0707:05EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/3/0707:03EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/3/0522:00GLOBELipella Pharmaceuticals Announces FDA Clearance of IND for..
2024/2/2807:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/2/2806:51EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2022:00GLOBELipella Pharmaceuticals to Present at PropThink Digital..
2024/2/0914:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/2/0807:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0206:09EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/1/2606:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/0406:59EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/12/2022:00GLOBELipella Pharmaceuticals Marks Successful First Year with..
2023/11/2907:28EDGAR2Form 8-K - Current report
2023/11/2306:05EDGAR2Form 8-K - Current report
2023/11/1420:22EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/11/1420:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1022:00PRNUSFDA Grants Orphan Designation for Lipella's LP-310 Drug..
2023/11/1006:07EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/11/0205:06EDGAR2Form S-1 - General form for registration of securities under..
2023/10/2605:05PRNUSLipella Pharmaceuticals Announces Closing of $2 Million..
2023/10/2421:00PRNUSLipella Pharmaceuticals Announces $2 Million Private..
2023/10/2021:00PRNUSLipella Pharmaceuticals Announces FDA Clearance of IND for..
2023/10/1105:05EDGAR2Form DEF 14A - Other definitive proxy statements
2023/9/2121:30PRNUSLipella Pharmaceuticals' Phase 2a Clinical Study Results..
2023/9/1120:38EDGAR2Form 8-K - Current report
2023/8/1505:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/1505:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0905:30EDGAR2Form 8-K - Current report
2023/8/0305:05EDGAR2Form 8-K - Current report
2023/5/1522:17PRNUSLipella Pharmaceuticals Reports First Quarter 2023 Financial..

最近閲覧した銘柄

Delayed Upgrade Clock